Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Dopamine D1 | 16 | 2021 | 293 | 3.890 |
Why?
|
Maternal Deprivation | 8 | 2024 | 48 | 3.130 |
Why?
|
Cocaine | 13 | 2021 | 961 | 2.620 |
Why?
|
Behavior, Animal | 17 | 2024 | 1866 | 2.510 |
Why?
|
Dopamine Uptake Inhibitors | 11 | 2021 | 297 | 2.090 |
Why?
|
Methylphenidate | 11 | 2018 | 488 | 1.950 |
Why?
|
Prefrontal Cortex | 20 | 2021 | 2212 | 1.910 |
Why?
|
Rats, Sprague-Dawley | 56 | 2024 | 8158 | 1.750 |
Why?
|
Dopamine | 21 | 2016 | 1595 | 1.650 |
Why?
|
Nucleus Accumbens | 15 | 2016 | 365 | 1.510 |
Why?
|
Cues | 6 | 2021 | 867 | 1.490 |
Why?
|
Receptors, Dopamine D2 | 15 | 2017 | 485 | 1.380 |
Why?
|
Stress, Psychological | 14 | 2024 | 4446 | 1.340 |
Why?
|
Exploratory Behavior | 4 | 2021 | 273 | 1.320 |
Why?
|
Rats | 61 | 2024 | 23711 | 1.290 |
Why?
|
Parvalbumins | 5 | 2024 | 260 | 1.280 |
Why?
|
Behavior, Addictive | 5 | 2022 | 462 | 1.260 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 13 | 2017 | 3701 | 1.150 |
Why?
|
Sex Characteristics | 11 | 2018 | 2629 | 1.050 |
Why?
|
Depression | 9 | 2024 | 8044 | 1.020 |
Why?
|
Cocaine-Related Disorders | 3 | 2015 | 460 | 1.020 |
Why?
|
Extinction, Psychological | 4 | 2015 | 371 | 1.010 |
Why?
|
Central Nervous System Stimulants | 12 | 2017 | 1174 | 0.980 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2024 | 48 | 0.930 |
Why?
|
Helplessness, Learned | 4 | 2018 | 28 | 0.850 |
Why?
|
Brain | 24 | 2022 | 26951 | 0.840 |
Why?
|
Neostriatum | 9 | 2002 | 246 | 0.810 |
Why?
|
Motor Activity | 9 | 2016 | 2687 | 0.760 |
Why?
|
Child Abuse | 6 | 2022 | 1067 | 0.740 |
Why?
|
Animals, Newborn | 12 | 2017 | 2672 | 0.740 |
Why?
|
Substance-Related Disorders | 7 | 2021 | 4371 | 0.710 |
Why?
|
Corpus Striatum | 12 | 2017 | 1233 | 0.650 |
Why?
|
Maternal Behavior | 2 | 2013 | 306 | 0.650 |
Why?
|
Guanfacine | 1 | 2018 | 51 | 0.630 |
Why?
|
Adolescent Development | 3 | 2014 | 282 | 0.620 |
Why?
|
Reward | 4 | 2016 | 963 | 0.600 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2015 | 432 | 0.590 |
Why?
|
Drug-Seeking Behavior | 1 | 2017 | 46 | 0.580 |
Why?
|
Receptor, trkB | 1 | 2018 | 125 | 0.570 |
Why?
|
Animals | 75 | 2024 | 167963 | 0.560 |
Why?
|
Gonadal Hormones | 1 | 2016 | 30 | 0.550 |
Why?
|
Child Abuse, Sexual | 3 | 2009 | 392 | 0.540 |
Why?
|
Motivation | 5 | 2018 | 1993 | 0.520 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 89 | 0.510 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2017 | 599 | 0.500 |
Why?
|
Receptors, GABA | 1 | 2017 | 305 | 0.500 |
Why?
|
Amygdala | 3 | 2018 | 1351 | 0.480 |
Why?
|
Receptors, Dopamine | 3 | 2016 | 292 | 0.480 |
Why?
|
Mothers | 2 | 2016 | 2186 | 0.480 |
Why?
|
Aging | 20 | 2015 | 8651 | 0.480 |
Why?
|
Ventral Tegmental Area | 1 | 2016 | 134 | 0.480 |
Why?
|
Clomipramine | 4 | 2015 | 54 | 0.470 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2015 | 1489 | 0.450 |
Why?
|
Impulsive Behavior | 4 | 2018 | 346 | 0.440 |
Why?
|
Binge-Eating Disorder | 1 | 2015 | 147 | 0.440 |
Why?
|
Cyclooxygenase 2 | 2 | 2017 | 599 | 0.440 |
Why?
|
Psychotropic Drugs | 2 | 2011 | 883 | 0.410 |
Why?
|
Memory, Short-Term | 2 | 2017 | 978 | 0.400 |
Why?
|
Narcotics | 2 | 2010 | 336 | 0.400 |
Why?
|
Age Factors | 18 | 2018 | 18416 | 0.400 |
Why?
|
Risk-Taking | 2 | 2016 | 998 | 0.400 |
Why?
|
Hyperthyroidism | 1 | 2014 | 291 | 0.400 |
Why?
|
Locomotion | 2 | 2014 | 387 | 0.390 |
Why?
|
Depressive Disorder | 3 | 2017 | 3726 | 0.380 |
Why?
|
Sexual Development | 1 | 2011 | 40 | 0.380 |
Why?
|
Neuropharmacology | 1 | 2011 | 20 | 0.380 |
Why?
|
Receptors, Dopamine D3 | 2 | 2008 | 107 | 0.360 |
Why?
|
Fluoxetine | 2 | 2013 | 733 | 0.360 |
Why?
|
Child of Impaired Parents | 1 | 2014 | 459 | 0.350 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2017 | 1132 | 0.350 |
Why?
|
Dizocilpine Maleate | 2 | 2008 | 172 | 0.350 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2013 | 489 | 0.350 |
Why?
|
Resilience, Psychological | 1 | 2018 | 768 | 0.350 |
Why?
|
Disease Models, Animal | 10 | 2018 | 18137 | 0.340 |
Why?
|
Mental Processes | 1 | 2011 | 245 | 0.340 |
Why?
|
Sex Factors | 9 | 2021 | 10547 | 0.340 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 599 | 0.320 |
Why?
|
Hypothyroidism | 1 | 2014 | 665 | 0.320 |
Why?
|
Stress, Physiological | 2 | 2008 | 1398 | 0.320 |
Why?
|
Frontal Lobe | 2 | 2012 | 1420 | 0.310 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2138 | 0.300 |
Why?
|
Developmental Disabilities | 2 | 2008 | 1504 | 0.300 |
Why?
|
Sexual Maturation | 3 | 2011 | 260 | 0.290 |
Why?
|
Conditioning, Classical | 2 | 2008 | 364 | 0.290 |
Why?
|
Oxidopamine | 3 | 2016 | 172 | 0.290 |
Why?
|
Male | 59 | 2021 | 359744 | 0.280 |
Why?
|
Association Learning | 2 | 2008 | 219 | 0.280 |
Why?
|
Anxiety | 5 | 2015 | 4538 | 0.280 |
Why?
|
Self Administration | 2 | 2018 | 390 | 0.280 |
Why?
|
Dopamine Agonists | 6 | 2010 | 352 | 0.270 |
Why?
|
Maze Learning | 3 | 2009 | 477 | 0.270 |
Why?
|
Neurobiology | 2 | 2006 | 137 | 0.260 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2008 | 448 | 0.250 |
Why?
|
Female | 46 | 2024 | 391270 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 15 | 2018 | 10827 | 0.250 |
Why?
|
Nervous System | 1 | 2008 | 543 | 0.250 |
Why?
|
Lentivirus | 2 | 2021 | 506 | 0.240 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 4 | 2010 | 54 | 0.230 |
Why?
|
Functional Laterality | 2 | 2002 | 2253 | 0.230 |
Why?
|
Apomorphine | 2 | 1994 | 149 | 0.230 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2012 | 893 | 0.220 |
Why?
|
Potassium | 4 | 1996 | 1313 | 0.220 |
Why?
|
Biological Factors | 2 | 2020 | 157 | 0.210 |
Why?
|
Adolescent | 18 | 2022 | 87810 | 0.210 |
Why?
|
Mental Disorders | 3 | 2016 | 6796 | 0.210 |
Why?
|
Biogenic Monoamines | 1 | 2002 | 50 | 0.210 |
Why?
|
Nicotine | 2 | 2020 | 677 | 0.210 |
Why?
|
Microdialysis | 7 | 2010 | 160 | 0.210 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2017 | 321 | 0.200 |
Why?
|
Conditioning, Operant | 3 | 2015 | 308 | 0.200 |
Why?
|
Benzodiazepines | 1 | 2008 | 1131 | 0.200 |
Why?
|
Human Development | 1 | 2003 | 123 | 0.200 |
Why?
|
Concept Formation | 1 | 2003 | 159 | 0.190 |
Why?
|
Cannabinoids | 1 | 2024 | 173 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 2001 | 586 | 0.190 |
Why?
|
Second Messenger Systems | 1 | 2002 | 202 | 0.190 |
Why?
|
Nerve Endings | 2 | 1998 | 105 | 0.190 |
Why?
|
Amphetamine-Related Disorders | 1 | 2001 | 77 | 0.190 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2282 | 0.190 |
Why?
|
Hippocampus | 4 | 2011 | 3738 | 0.190 |
Why?
|
Social Isolation | 2 | 2018 | 362 | 0.180 |
Why?
|
Adaptation, Physiological | 2 | 2004 | 1296 | 0.180 |
Why?
|
Interneurons | 2 | 2011 | 591 | 0.180 |
Why?
|
Neurons | 5 | 2016 | 9426 | 0.170 |
Why?
|
Milk | 2 | 1993 | 443 | 0.170 |
Why?
|
Sulpiride | 2 | 1996 | 15 | 0.170 |
Why?
|
Glutamic Acid | 2 | 2016 | 1167 | 0.170 |
Why?
|
Corpus Callosum | 1 | 2004 | 749 | 0.170 |
Why?
|
Synapses | 2 | 2008 | 1757 | 0.160 |
Why?
|
Raphe Nuclei | 1 | 1999 | 103 | 0.160 |
Why?
|
Analysis of Variance | 6 | 2008 | 6238 | 0.160 |
Why?
|
Cerebrovascular Circulation | 2 | 2010 | 2733 | 0.160 |
Why?
|
Child | 18 | 2022 | 79806 | 0.160 |
Why?
|
Psychopathology | 1 | 2022 | 429 | 0.160 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 2016 | 370 | 0.160 |
Why?
|
Ovariectomy | 2 | 2016 | 611 | 0.160 |
Why?
|
Receptors, Neurotransmitter | 2 | 2016 | 174 | 0.150 |
Why?
|
Genetic Vectors | 2 | 2021 | 3380 | 0.150 |
Why?
|
Serotonin | 2 | 1999 | 1040 | 0.150 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 91 | 0.150 |
Why?
|
Cyclic AMP | 1 | 2002 | 1456 | 0.150 |
Why?
|
Adolescent Behavior | 2 | 2020 | 1175 | 0.150 |
Why?
|
Dopamine Antagonists | 5 | 2008 | 288 | 0.150 |
Why?
|
Autoradiography | 4 | 2003 | 730 | 0.150 |
Why?
|
Cerebral Cortex | 3 | 2012 | 5761 | 0.140 |
Why?
|
Tetrahydronaphthalenes | 1 | 1997 | 86 | 0.140 |
Why?
|
Brain Chemistry | 3 | 2008 | 959 | 0.140 |
Why?
|
Catecholamines | 1 | 1998 | 385 | 0.140 |
Why?
|
Tetrodotoxin | 2 | 1998 | 246 | 0.140 |
Why?
|
Quinpirole | 5 | 2010 | 32 | 0.140 |
Why?
|
Limbic System | 1 | 1999 | 419 | 0.140 |
Why?
|
Amphetamines | 1 | 2017 | 143 | 0.140 |
Why?
|
Synaptophysin | 2 | 2008 | 139 | 0.140 |
Why?
|
Random Allocation | 2 | 2013 | 2394 | 0.130 |
Why?
|
Risk | 1 | 2008 | 9631 | 0.130 |
Why?
|
Consummatory Behavior | 1 | 2015 | 6 | 0.130 |
Why?
|
Neuronal Plasticity | 1 | 2004 | 1430 | 0.130 |
Why?
|
Tryptophan Hydroxylase | 1 | 2016 | 94 | 0.130 |
Why?
|
Estrogens | 1 | 2002 | 1520 | 0.130 |
Why?
|
Receptors, Opioid, kappa | 2 | 1993 | 138 | 0.120 |
Why?
|
Bupropion | 1 | 1997 | 304 | 0.120 |
Why?
|
Neuroimmunomodulation | 1 | 2017 | 177 | 0.120 |
Why?
|
Spatial Behavior | 1 | 2015 | 88 | 0.120 |
Why?
|
Sucrose | 1 | 2015 | 156 | 0.120 |
Why?
|
RNA, Messenger | 3 | 2016 | 12766 | 0.120 |
Why?
|
Species Specificity | 2 | 2011 | 2418 | 0.120 |
Why?
|
Adrenergic Agents | 1 | 2014 | 74 | 0.110 |
Why?
|
Pregnancy | 7 | 2014 | 29749 | 0.110 |
Why?
|
Fetal Movement | 1 | 1993 | 21 | 0.110 |
Why?
|
Reflex, Stretch | 1 | 1993 | 23 | 0.110 |
Why?
|
Sucking Behavior | 1 | 1993 | 28 | 0.110 |
Why?
|
Time Factors | 9 | 2014 | 40165 | 0.110 |
Why?
|
Denmark | 2 | 2014 | 760 | 0.110 |
Why?
|
Saliva | 1 | 2017 | 820 | 0.110 |
Why?
|
Central Nervous System Depressants | 1 | 2014 | 164 | 0.110 |
Why?
|
Stereotyped Behavior | 1 | 1993 | 135 | 0.100 |
Why?
|
Humans | 32 | 2022 | 760621 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 8 | 2021 | 36290 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2014 | 244 | 0.100 |
Why?
|
Nicotinic Agonists | 1 | 2014 | 265 | 0.100 |
Why?
|
Dopamine Agents | 2 | 2008 | 189 | 0.100 |
Why?
|
Nitrobenzenes | 1 | 2011 | 66 | 0.100 |
Why?
|
Testosterone | 1 | 2002 | 2470 | 0.100 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4744 | 0.090 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2010 | 42 | 0.090 |
Why?
|
Space Perception | 1 | 2014 | 464 | 0.090 |
Why?
|
Environment | 3 | 2008 | 1118 | 0.090 |
Why?
|
Nesting Behavior | 1 | 2009 | 17 | 0.090 |
Why?
|
Propylamines | 1 | 2010 | 161 | 0.090 |
Why?
|
Thyroid Gland | 1 | 2016 | 1168 | 0.090 |
Why?
|
Microinjections | 1 | 2010 | 321 | 0.080 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2010 | 186 | 0.080 |
Why?
|
Birth Order | 1 | 2009 | 95 | 0.080 |
Why?
|
Drugs, Investigational | 1 | 2011 | 214 | 0.080 |
Why?
|
Amphetamine | 3 | 2010 | 224 | 0.080 |
Why?
|
Neurotransmitter Agents | 2 | 2011 | 663 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 412 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 564 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2008 | 700 | 0.080 |
Why?
|
Drug Interactions | 3 | 2008 | 1428 | 0.080 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2008 | 114 | 0.080 |
Why?
|
Stereoisomerism | 1 | 2009 | 617 | 0.080 |
Why?
|
Norepinephrine | 1 | 2010 | 900 | 0.070 |
Why?
|
Ethanol | 1 | 2014 | 1323 | 0.070 |
Why?
|
Pituitary-Adrenal System | 2 | 2008 | 552 | 0.070 |
Why?
|
Dietary Fats | 1 | 2015 | 1992 | 0.070 |
Why?
|
Levodopa | 2 | 1998 | 217 | 0.070 |
Why?
|
Substantia Nigra | 1 | 2008 | 350 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1739 | 0.070 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 3 | 1998 | 63 | 0.070 |
Why?
|
Avoidance Learning | 1 | 2008 | 248 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2014 | 26181 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 1999 | 1544 | 0.070 |
Why?
|
Fetus | 1 | 1993 | 1859 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1180 | 0.060 |
Why?
|
Haplorhini | 1 | 2006 | 529 | 0.060 |
Why?
|
Siblings | 1 | 2009 | 824 | 0.060 |
Why?
|
Medial Forebrain Bundle | 1 | 2005 | 43 | 0.060 |
Why?
|
Administration, Oral | 2 | 2009 | 4035 | 0.060 |
Why?
|
Hormones | 1 | 2008 | 867 | 0.060 |
Why?
|
Blotting, Western | 2 | 2012 | 5039 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2628 | 0.060 |
Why?
|
Demography | 1 | 2009 | 1650 | 0.060 |
Why?
|
Young Adult | 3 | 2022 | 58741 | 0.060 |
Why?
|
Memory Disorders | 1 | 2011 | 1197 | 0.060 |
Why?
|
Adult | 8 | 2022 | 219994 | 0.060 |
Why?
|
Social Environment | 1 | 2008 | 1022 | 0.060 |
Why?
|
Nerve Net | 2 | 2016 | 2261 | 0.050 |
Why?
|
Salicylamides | 2 | 2005 | 33 | 0.050 |
Why?
|
Long-Term Potentiation | 1 | 2005 | 293 | 0.050 |
Why?
|
Radioligand Assay | 1 | 2003 | 366 | 0.050 |
Why?
|
Immobilization | 1 | 2003 | 230 | 0.050 |
Why?
|
Swimming | 1 | 2003 | 207 | 0.050 |
Why?
|
Reference Values | 2 | 2004 | 4925 | 0.050 |
Why?
|
Cohort Studies | 2 | 2016 | 41335 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1988 | 0.050 |
Why?
|
Salmonella Food Poisoning | 1 | 2001 | 12 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3301 | 0.050 |
Why?
|
Forecasting | 1 | 2011 | 2932 | 0.050 |
Why?
|
Euphoria | 1 | 2001 | 65 | 0.050 |
Why?
|
Salmonella enterica | 1 | 2001 | 75 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2014 | 3185 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2496 | 0.050 |
Why?
|
Sulfonamides | 1 | 2011 | 1977 | 0.050 |
Why?
|
Child, Preschool | 5 | 2017 | 42063 | 0.050 |
Why?
|
Calcium | 1 | 1994 | 5725 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39261 | 0.050 |
Why?
|
Memory | 1 | 2010 | 2179 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2002 | 323 | 0.040 |
Why?
|
Regional Blood Flow | 2 | 2016 | 1490 | 0.040 |
Why?
|
Orchiectomy | 1 | 2002 | 470 | 0.040 |
Why?
|
Gastroenteritis | 1 | 2001 | 237 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2009 | 2062 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 491 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 2001 | 344 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12531 | 0.040 |
Why?
|
Weaning | 1 | 1999 | 103 | 0.040 |
Why?
|
Infant | 3 | 2014 | 36060 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2011 | 2890 | 0.040 |
Why?
|
Homovanillic Acid | 2 | 1998 | 75 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.040 |
Why?
|
Clorgyline | 1 | 1997 | 14 | 0.040 |
Why?
|
Regression Analysis | 1 | 2008 | 6360 | 0.040 |
Why?
|
Selegiline | 1 | 1997 | 32 | 0.040 |
Why?
|
Kinetics | 2 | 1996 | 6377 | 0.040 |
Why?
|
Carbolines | 1 | 1999 | 288 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2008 | 6015 | 0.040 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1997 | 155 | 0.040 |
Why?
|
Reaction Time | 1 | 2003 | 2075 | 0.040 |
Why?
|
Neurotoxins | 1 | 1998 | 240 | 0.040 |
Why?
|
Psychology, Experimental | 1 | 1996 | 5 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3604 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 24123 | 0.030 |
Why?
|
Akathisia, Drug-Induced | 1 | 1995 | 67 | 0.030 |
Why?
|
Models, Animal | 1 | 2002 | 2117 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 21392 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2003 | 1428 | 0.030 |
Why?
|
Disease Progression | 2 | 2011 | 13502 | 0.030 |
Why?
|
Acridines | 1 | 1994 | 19 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2008 | 2859 | 0.030 |
Why?
|
Ergolines | 1 | 1994 | 57 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4048 | 0.030 |
Why?
|
Nerve Tissue Proteins | 3 | 2008 | 4407 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1998 | 2262 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 1998 | 748 | 0.030 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 20 | 0.030 |
Why?
|
Chemoreceptor Cells | 1 | 1993 | 89 | 0.030 |
Why?
|
Taste Buds | 1 | 1993 | 24 | 0.030 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2010 | 415 | 0.030 |
Why?
|
Dialysis | 1 | 1992 | 75 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10756 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9411 | 0.030 |
Why?
|
Inpatients | 1 | 2004 | 2581 | 0.030 |
Why?
|
Receptors, Opioid, mu | 1 | 1993 | 166 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 1992 | 399 | 0.030 |
Why?
|
Drug Tolerance | 1 | 1994 | 369 | 0.030 |
Why?
|
Long-Term Care | 1 | 2016 | 632 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 1997 | 1035 | 0.020 |
Why?
|
Body Weight | 1 | 2002 | 4611 | 0.020 |
Why?
|
Models, Neurological | 1 | 1999 | 1758 | 0.020 |
Why?
|
Pyrrolidines | 1 | 1993 | 340 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15840 | 0.020 |
Why?
|
Fear | 1 | 1999 | 1462 | 0.020 |
Why?
|
Phenanthridines | 1 | 2010 | 51 | 0.020 |
Why?
|
Child Development | 1 | 2002 | 2285 | 0.020 |
Why?
|
Brain Mapping | 1 | 2005 | 6568 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2016 | 1114 | 0.020 |
Why?
|
Thalamus | 1 | 2016 | 1041 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2016 | 65017 | 0.020 |
Why?
|
Mice | 2 | 2015 | 81208 | 0.020 |
Why?
|
Microdissection | 1 | 2008 | 151 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2471 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2009 | 80372 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11071 | 0.020 |
Why?
|
Psychotic Disorders | 1 | 2003 | 3193 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2003 | 4555 | 0.020 |
Why?
|
Antimalarials | 1 | 1994 | 906 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1175 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 998 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 74359 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1997 | 3707 | 0.020 |
Why?
|
Analgesics | 1 | 1993 | 1065 | 0.020 |
Why?
|
Dextroamphetamine | 2 | 1996 | 134 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3804 | 0.020 |
Why?
|
Self Stimulation | 1 | 2005 | 47 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1997 | 4938 | 0.010 |
Why?
|
Gestational Age | 1 | 1993 | 3565 | 0.010 |
Why?
|
Receptors, Dopamine D4 | 1 | 2004 | 170 | 0.010 |
Why?
|
Ion Channels | 1 | 2008 | 1043 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2008 | 1167 | 0.010 |
Why?
|
Cesarean Section | 1 | 1992 | 1385 | 0.010 |
Why?
|
Ferric Compounds | 1 | 2005 | 377 | 0.010 |
Why?
|
Attention | 2 | 2004 | 2387 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3215 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12427 | 0.010 |
Why?
|
Benzazepines | 1 | 2004 | 311 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 6189 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4573 | 0.010 |
Why?
|
Serotyping | 1 | 2001 | 324 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3775 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2005 | 1735 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2008 | 1889 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5797 | 0.010 |
Why?
|
Pyrroles | 1 | 2004 | 1137 | 0.010 |
Why?
|
Parkinson Disease, Secondary | 1 | 1998 | 122 | 0.010 |
Why?
|
Putamen | 1 | 1998 | 291 | 0.010 |
Why?
|
Life Change Events | 1 | 2002 | 952 | 0.010 |
Why?
|
Biological Evolution | 1 | 2003 | 1074 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1998 | 389 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29658 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1878 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 1997 | 324 | 0.010 |
Why?
|
Cattle | 1 | 2001 | 3847 | 0.010 |
Why?
|
Habituation, Psychophysiologic | 1 | 1996 | 147 | 0.010 |
Why?
|
Mitochondria | 1 | 2008 | 3600 | 0.010 |
Why?
|
Aotus trivirgatus | 1 | 1994 | 36 | 0.010 |
Why?
|
Videotape Recording | 1 | 1996 | 337 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2002 | 1803 | 0.010 |
Why?
|
Oxygen | 1 | 2005 | 4193 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9501 | 0.010 |
Why?
|
Pyridines | 1 | 2004 | 2879 | 0.010 |
Why?
|
Swine | 1 | 2001 | 5899 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16546 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11903 | 0.010 |
Why?
|
Drug Resistance | 1 | 1994 | 1617 | 0.000 |
Why?
|
Malaria, Falciparum | 1 | 1994 | 1076 | 0.000 |
Why?
|
Plasmodium falciparum | 1 | 1994 | 1742 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 58995 | 0.000 |
Why?
|
Software | 1 | 1996 | 4419 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1997 | 8056 | 0.000 |
Why?
|
Aged | 1 | 2008 | 169152 | 0.000 |
Why?
|